Gliomatosis cerebri pathophysiology

Gliomatosis cerebri Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gliomatosis cerebri from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gliomatosis cerebri pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gliomatosis cerebri pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gliomatosis cerebri pathophysiology
CDC on Gliomatosis cerebri pathophysiology
Gliomatosis cerebri pathophysiology in the news
Blogs on Gliomatosis cerebri pathophysiology
Directions to Hospitals Treating Gliomatosis cerebri
Risk calculators and risk factors for Gliomatosis cerebri pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Pathophysiology

Pathogenesis

Gliomatosis cerebri may be primary (de novo) or secondary, with the latter as a result from the spreading of a more focal glioma. Gliomatosis cerebri can contain areas of WHO grade 2 or 3 tumors, and rarely grade 4.

References

Template:WikiDoc Sources